Mutations in KRAS are frequently found in pancreatic ductal adenocarcinoma (PDA), and expression of oncogenic KrasG12D mutation in mouse pancreatic tissue initiates the development of PDA. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.